Biosimilar Solutions

Affordability Access Uncompromising Quality

Biosimilar Solutions is a leading global biosimilar company. We are committed to improving patient lives by expanding access to life-changing biologic medicines.

 

Executive Summary

 
es-01.png

Biosimilar company with world class Scientific, Manufacturing, and Commercial capabilities at the Executive and Operator level.

 
es-02.png

Unique and progressive partnership agreement with $65B biologics developer that enables access to 14 biologic candidates and $50M in cost sharing.

 
es-03.png

Low risk 4 product portfolio launching from 2022 to 2025 into large growing markets.

 
es-04.png

Optimized for low-cost delivery model and investor return on capital.